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The regenerative capacity of the liver is well known, and the mechanisms that regulate this process have been extensively studied
using experimental model systems including surgical resection and hepatotoxin exposure. The response to primary mitogens has
also been used to investigate the regulation of hepatocellular proliferation. Such analyses have identiﬁed many speciﬁc cytokines
and growth factors, intracellular signaling events, and transcription factors that are regulated during and necessary for normal
liver regeneration. Nevertheless, the nature and identities of the most proximal events that initiate hepatic regeneration as well as
those distal signals that terminate this process remain unknown. Here, we review the data implicating acute alterations in lipid
metabolism as important determinants of experimental liver regeneration and propose a novel metabolic model of regeneration
based on these data. We also discuss the association between chronic hepatic steatosis and impaired regeneration in animal models
and humans and consider important areas for future research.
1.Introduction
The liver has remarkable capacity to recover from injury.
Such regenerative potential is essential for survival following
partial hepatic resection (e.g., for tumor removal or live-
donorlivertransplantation)andfromacuteandchronicliver
injury secondary to toxins, infections, immune dysfunction,
metabolic diseases, or other causes [1–3]. Nevertheless, liver
diseases remain an important cause of morbidity and mor-
tality,andinadequatehepaticregenerationlikelycontributes.
Based on these considerations, the mechanisms that regulate
liver regeneration continue to be the subject of intense
research, with hope that the knowledge gained will lead to
novelstrategieswithwhichtoimprovetheoutcomesofmany
liver diseases. A number of studies have identiﬁed fatty liver
as an important risk factor for impaired liver regeneration in
humans and experimental animal models. In apparent dis-
tinction to those observations however, and still a lingering
paradox in the literature, a number of reports suggest that
the transient hepatocellular fat accumulation characteristic
of early regeneration following partial hepatectomy (PH) in
rodents is actually required for physiological liver regenera-
tion. Here, we review these data, propose a hypothesis for the
seemingly dichotomous relationship of chronic versus acute
hepatic fat accumulation on liver regeneration, and consider
important areas for future research.
2. ExperimentalLiver Regeneration
The best characterized and most readily controlled exper-
imental model for investigating the molecular, cellular,
and physiologic mechanisms that control liver regeneration
has been PH in rodents [4]. In the most typically used
version of this paradigm, that is, “two-thirds” PH, the
anesthetized rodent is subjected to midventral laparotomy
with sequential ligation and resection of the left and median
hepatic lobes followed by closure of the surgical wounds
andrecovery.Subsequentregenerationisassessedbyanalyses
of hepatocellular proliferation, liver mass, gene and protein
expression, and signaling events at serial time points after
the surgery. Studies using this experimental system show
that regeneration after PH is precisely regulated in both2 International Journal of Hepatology
its initiation and duration, terminating only when the
original liver-to-body mass ratio is restored. Furthermore,
this response does not require recruitment or mobilization
of either a resident or exogenous stem cell population.
Rather, all of the normally quiescent hepatocytes in the
mature liver have the potential to proliferate in response to
partial hepatic resection [5]. Pharmacological and genetic
manipulations of animals subjected to PH have identiﬁed
manysignals,includingcytokines(e.g.,tumornecrosisfactor
α (TNFα) and interleukin 6 (IL6)), growth factors (e.g.,
hepatocyte growth factor (HGF), epidermal growth factor-
receptor ligands, and ﬁbroblast growth factors), intracellular
signaling events (e.g., Wnt/β-catenin), and transcription
factors (e.g., NFκB, STAT3, CREB, C/EBPβ,A P 1 ,F X R ,a n d
LXR), that are regulated in response to PH and inﬂuence the
subsequent hepatic regenerative response (reviewed in [1–
3, 5, 6]). Those signals, some of which are initiated within
minutes of surgical resection, promote restoration of normal
hepatic mass, architecture, and function over the ensuing
days, after which regeneration ceases.
OneadvantageofthePHmodelofliverregenerationover
others is the absence of injury to the remnant liver tissue fol-
lowing the (surgically induced) regenerative stimulus, which
therebyminimizespotentialconfounderstointerpretationof
the functional speciﬁcity of induced signals for the regen-
erative response itself. Nevertheless, experimental models of
toxin-induced liver regeneration (e.g., carbon tetrachloride
(CCl4), thioacetamide [7, 8]) have also been extensively used
to investigate regenerative mechanisms, and the importance
ofseveralregulatorypathwaysidentiﬁedinthePHmodelhas
been shown to be conserved in such paradigms [9, 10]. In
contrast, the hepatocellular proliferative response to primary
mitogens does not depend upon TNFα,H G F ,N F κB, and
several other signals implicated as important in hepatic
insuﬃciency-inducedliverregeneration[11–16].Despitethe
broad knowledge gained from almost a century of studies
using these models, the nature and identities of the most
proximal events that initiate hepatic regeneration as well as
the distal events that terminate this process are still not
known.
3.The Metabolic Response to Hepatic
Insufﬁciency and Liver Regeneration
Liver mass is maintained or recovered in precise proportion
to body mass, giving rise to the concept of an intrinsic
regulator of liver:body mass ratio, that is, the “hepatostat”
[5, 6]. Amongst its many essential functions, the liver
plays critical roles in the regulation of systemic metabolism
and extrahepatic energy consumption, which themselves are
inﬂuenced by body mass [17]. Together, these considerations
suggest that changes in intermediary metabolism in response
to hepatic insuﬃciency could contribute essential signals
for initiation of liver regeneration, and, conversely, that
restoration of metabolic homeostasis after recovery of the
normal liver:body mass ratio might provide signals that
terminate this response. Several experimental observations
support such a metabolic model of liver regeneration.
3.1. Glucose Metabolism during Liver Regeneration. Consis-
tent with the liver’s central role in gluconeogenesis, rodents
subjected to PH become hypoglycemic. Extending this
paradigm, other studies show that either intravenous or
enteral dextrose supplementation suppresses both PH- [18–
24] and toxin- (CCl4, thioacetamide; [25, 26]a n dJ .H u a n g
and D.A. Rudnick, unpublished observations) -induced hep-
atocellular proliferation. Similarly, dietary caloric restriction
accelerates onset of hepatocellular proliferation in response
to surgical- or toxin-induced hepatic insuﬃciency [27, 28].
Circulating insulin levels decline in response to PH-induced
hypoglycemia (and are augmented by dextrose supplemen-
tation [18]), and, interestingly, hepatocellular proliferation
in models of toxin-induced liver injury is accelerated and
augmented in mice with streptozotocin-induced insulin-
deﬁcient diabetes [29, 30]. Nevertheless, it remains to be
established if changes in insulin signaling mediate the
eﬀects of dextrose supplementation on liver regeneration
in such models. Somewhat paradoxically, studies have also
shown that insulin supplementation reverses hepatic lobar
atrophy in response to portacaval shunting in vivo and that
insulin augments the activity of hepatocyte mitogens in
cell culture [5]. This latter observation is consistent with
studies, including those noted above, demonstrating that
diﬀerences exist between the signals that regulate hepatocel-
lular proliferation in response to surgical- or toxin-induced
loss of liver mass and those that determine mitogen-induced
proliferation.
Dextrose-mediatedinhibitionofPH-inducedliverregen-
erationisassociatedwithdisruptionofmanysignalingevents
identiﬁed as important for regeneration. For example, provi-
sion of supplemental dextrose augments hepatic expression
of the mitoinhibitory factors C/EBPα, p21, and p27 and
suppresses expression of the proregenerative transcriptional
regulator, FoxM1, in animals subjected to PH [18]. Con-
sistent with these ﬁndings, induction of proregenerative
signals, including IL6, transforming growth factor α (TGFα),
and HGF, is accelerated by caloric restriction in toxin-
(thioacetamide)-induced liver regeneration [28]. Together,
these observations support a model in which the hypo-
glycemicresponsetohepaticinsuﬃciencyinitiatesthesignals
that promote liver regeneration. Many of the regenerative
signals that are disrupted by dextrose supplementation are
also deranged in association with the impaired regenerative
response observed in aged animals subjected to PH [31, 32].
Those changes in older mice appear to be mediated, at
least in part, by age-dependent epigenetic eﬀects [33, 34].
Together, these ﬁndings support a model in which the
metabolic responses to hepatic insuﬃciency after PH (e.g.,
hypoglycemia) activate a transcriptional network through
pathways including epigenetic regulation. In contrast to
PH-induced liver regeneration, toxin-induced regeneration
is undiminished in old versus young animals [35]. The
mechanisms responsible for this diﬀerence are unknown and
merit further investigation.
3.2. Systemic Catabolism during Liver Regeneration. The ob-
servations noted above implicate hypoglycemia and sub-
sequently induced alterations in systemic metabolism asInternational Journal of Hepatology 3
modulators of physiological liver regeneration. This consid-
eration has prompted further investigation of the metabolic
response to hepatic insuﬃciency in experimental models of
regeneration. Recent reports have characterized the stereo-
typical decline in systemic lean and adipose tissue stores
and the ensuing rise in circulating and hepatic free fatty
acids and speciﬁc amino acids that occur in response to PH
prior to the onset of regeneration [36–38]. Those analyses
also show that speciﬁc alterations in metabolism, like the
regenerativeresponseitself,occurinproportiontotheextent
of hepatic insuﬃciency [36]. For example, two-thirds PH
resultsinasigniﬁcantlygreaterlossofsystemicadiposestores
(and a more robust hepatocellular proliferative response)
thandoesone-thirdhepatectomy[36].Systemicfatdepletion
has also been observed in various models of toxin-induced
liver regeneration [36, 39]. These ﬁndings together suggest
that catabolism of systemic adipose tissue might regulate the
hepatic regenerative response to surgical and toxin-induced
loss of liver mass.
3.3. Hepatic and Systemic Lipid Metabolism during Liver Re-
generation. As noted above, it has long been recognized that
the early regenerating liver transiently accumulates hepato-
cellular fat after PH [40–43]. Other work has demonstrated
fat accumulation concomitant with cellular proliferation
in primary hepatocyte culture [44], raising the possibility
that fat accumulation might in turn regulate hepatocyte
proliferation. Furthermore, the patterns of hepatic mRNA
induction during early PH-stimulated liver regeneration
suggest the existence of a conserved transcriptional pro-
gram leading to regulated transient “steatosis” during the
regenerative response [45, 46] .T h er o l eo fe n d o g e n o u s
hepatic lipogenesis in regulating liver regeneration is less
clear. Increased de novo hepatic fatty acid production has
been reported in regenerating liver [43], but mice with
liver-speciﬁc disruption of fatty acid synthase expression
(i.e., FASKOL mice, [47]) exhibit comparable hepatic fat
accumulation (and liver regeneration) after PH compared to
that in wild-type controls, strongly suggesting that de novo
hepatic lipogenesis is not required for the development of
such transient hepatic steatosis or the regenerative response
[37]. These and other ﬁndings point to systemic adipose
tissue as the primary source of the lipid that accumulates in
regenerating liver [39, 40].
4. HepaticSteatosis during
ExperimentalLiver Regeneration
A number of experimental observations provide support for
the possibility that the alterations in hepatic and systemic
lipid metabolism discussed above are essential for normal
liver regeneration. For example, older studies have noted
increased dependency following PH of regenerating liver on
β-oxidation of fatty acids for energy production [22, 48].
Indeed, it has been speculated that the inhibitory eﬀect
of dextrose supplementation on liver regeneration might
be secondary to the suppressive eﬀect of such supplemen-
tation on the release of free fatty acids from systemic
adipose stores, and infusion of an inhibitor of β-oxidation,
((+)-octanoylcarnitine), has been reported to impair regen-
eration [48]. Moreover, parenteral administration of lipid
emulsions or of carnitine, which mediates uptake of acyl
groupsintomitochondria forβ-oxidation,hasbeenreported
to accelerate PH-induced regeneration [22], and dietary
supplementation with palmitate and carnitine augments
toxin- (thioacetamide)-induced hepatocellular proliferation
[49]. However, questions about the role of alterations in β-
oxidation have been raised by analyses of PPARα knockout
mice in which β-oxidation is dysregulated. Some reports
demonstrate normal PH-induced regeneration [37, 50], and
others show impaired regeneration [51, 52] in these animals.
More recent studies have reported inhibition of liver regen-
eration by various experimental interventions that decrease
hepaticfataccumulationafterpartialhepatectomy,including
both pharmacological (e.g., cloﬁbrate [53], leptin [45], or
propranolol [54] supplementation) and genetic (e.g., liver-
speciﬁc disruption of glucocorticoid receptor expression,
[45]) strategies. Those ﬁndings collectively imply a requisite
role for hepatic steatosis in liver regeneration. However, as
alluded to above, other ﬁndings raise questions about the
speciﬁc function of hepatic fat accumulation during normal
regeneration. For example, fat accumulation is suppressed
but regeneration proceeds normally following PH in liver
fatty acid binding protein (L-Fabp) knockout mice [37].
In addition, caveolin 1-null mice exhibit reduced hepatic
steatosis after PH, with regeneration reported to be impaired
in one study [55] but not another [56]. Finally, regeneration
proceeds normally in mice with intestine-speciﬁc deletion
of the microsomal triglyceride transfer protein (MTP-IKO),
which is essential for intestinal absorption of dietary fat
and which exhibit decreased peripheral adipose tissue [37].
Importantly, hepatectomy-induced fat accumulation was
reduced but not completely abrogated in L-Fabp-null and
MTP-IKO mice [37], leading to speculation about the
existence of a threshold of adaptive lipogenesis essential for
regeneration but not inﬂuenced in those models. The role
of mobilization of lipid from adipose tissue stores during
PH- and toxin-induced liver regeneration has also been
investigated by analyses of fatty liver dystrophy (ﬂd)m i c e ,
which have a paucity of systemic adipose tissue as a result
of global disruption of Lpin1 expression [57]. ﬂd mice
exhibitreducedhepatocellulartriglycerideaccumulationand
proliferation with augmented hepatic p21 expression after
PH compared to littermate controls [36]. ﬂd mice also
display increased mortality in response to CCl4-induced liver
injury [36]. Taken together, these data support a model in
which metabolism of systemic adipose tissue in response to
hepatic insuﬃciency promotes initiation of hepatocellular
proliferation.However,theydonotestablishthemechanisms
responsible.
An important caveat to the analyses of ﬂd mice is that
the target gene of interest, Lpin1, i se x p r e s s e di nl i v e ra n d
muscle in addition to adipose tissue, and its expression is
globally disrupted in ﬂd mice [57]. Thus, Lpin1 might have
eﬀects on hepatic steatosis and hepatocellular proliferation
duringliverregenerationdependentonitshepaticexpression
and independent of its eﬀects on systemic adipose tissue
stores. Interestingly, hepatic Lpin1 expression is induced4 International Journal of Hepatology
after PH, and such induction is attenuated in liver-speciﬁc
glucocorticoid receptor null mice, in which (as noted above)
the metabolic and hepatocellular proliferative responses to
PH are deranged ([45] and D. A. Rudnick, unpublished
observations). These ﬁndings, together with the known
pleiotropic functions of the protein product of Lpin1 (lipin1,
[58]) suggest several potential alternative mechanisms to
explain the impaired regenerative phenotype in ﬂd mice
[36]). For example, lipin1 ampliﬁes peroxisome proliferator-
activated receptor gamma coactivator 1α-( P G C 1 α-) regu-
lated transcription in hepatocytes to increase expression of
genesencodingenzymesinvolvedinfattyacidoxidation(and
known to be regulated during liver regeneration, [59, 60]).
Lipin1 also stimulates peroxisome proliferator-activated
receptor γ-( P P A R γ-) dependent adipogenic gene expression
inadipocytes[61].Finally,lipin1isaphosphatidicacidphos-
phatase enzyme, catalyzing the conversion of phosphatidic
acid (PA) to diacylglycerol (DAG, [62]). This reaction plays a
key role in triglyceride and phospholipid biosynthesis [63].
PA and DAG also function as lipid second messengers in
protein kinase C activation [64], which occurs during liver
regeneration [65–67]. Thus, loss of the transcriptional or
enzymatic activities of hepatic lipin1 might contribute to
impaired regeneration in ﬂd mice.
A further consideration, not exclusive of those outlined
above, is that alterations in hepatic and circulating pools of
cholesterol might play a role in some phases of liver regener-
ation. This possibility has emerged from analyses in PCSK9
knockout mice, which exhibit decreased pools of circulating
cholesterol,impairedregeneration,andhepaticnecrosisafter
PH,allofwhicharereversedbyhighcholesterolfeeding[68].
Additional support for this idea comes from demonstration
thatligand-inducedliverXreceptor(LXR)activationinmice
subjected to PH alters plasma and hepatic cholesterol pools
and impairs liver regeneration [69].
5. A Metabolic Model of LiverRegeneration
The data summarized above suggest that alterations in lipid
metabolism that occur in response to hepatic insuﬃciency
contribute to the initiation of both resection- and toxin-
induced liver regeneration. Although the speciﬁc mecha-
nisms that couple changes in lipid metabolism to onset of
hepatic regeneration have not been elucidated, several possi-
bilities are worthy of consideration (Figure 1). For example,
lipids delivered from the periphery or synthesized de novo
in response to partial hepatic resection or other liver injury
might serve simply as the substrate for energy production
[70] or for membrane synthesis required for hepatocellular
proliferation. Another intriguing consideration is that lipid-
derived metabolites might inﬂuence regenerative signaling
pathways via transcriptional or epigenetic mechanisms. Sev-
eral lines of evidence provide indirect support for this latter
concept. For example, the transcriptional activities of the
nuclear steroid hormone transcription factors PPARα,F X R ,
and LXR, which have each been implicated as important
during PH-induced liver regeneration [51, 52, 69, 71], are
regulated by binding to speciﬁc classes of phospholipid [72],
bile acids [71], or oxysterols [69], respectively. In addition,
certain fatty acids have been reported to inﬂuence the acety-
lation state of metabolic enzymes in hepatocytes [73]a n d
thus might also regulate epigenetic changes in regenerating
liver. Finally, hepatic insuﬃciency-induced alterations in
lipid metabolism might aﬀect physiologic liver regeneration
via adipose-derived hormones. Indeed, the inﬂuence of
adipokines on regeneration has been suggested by studies
showing inhibition of PH-induced liver regeneration in
wildtype mice by leptin supplementation [45] and impaired
regeneration in adiponectin knockout mice [74, 75].
6. ImpairedLiverRegenerationinExperimental
Models andHumanswithFattyLiverDisease
The inﬂuence of adipose metabolism on liver regeneration
has also been demonstrated by the recognized association
between chronic hepatic steatosis and impaired regeneration
in experimental animal models. Leptin-deﬁcient (ob/ob)
[76–79] and -resistant (db/db)[ 80, 81], diabetic KK-A(y)
[82], “Western” [83] and high-fructose [84] diet-fed mice,
and leptin-resistant obese Zucker rats [85, 86], each of
which exhibit hepatic steatosis, have all been reported to
demonstrate impeded regeneration after PH or CCl4 admin-
istration. In contrast, liver regeneration is not impaired
in models of mild hepatic steatosis, including orotic acid-
[86] and choline- [87] deﬁcient diet-fed rats, leading some
investigators to speculate that the degree of steatosis is
important in determining its eﬀect on liver regeneration.
Consistent with that interpretation, liver regeneration is
variably aﬀected in animals administered a methionine-
choline deﬁcient (MCD), a phenotype dependent on the
magnitude of steatosis [86, 88–91]. Despite these many
studies linking chronic hepatic steatosis with impaired liver
regeneration, the mechanisms responsible remain enigmatic.
Moreover, the basis for the diﬀerences in the inﬂuence of
chronic and acute hepatic fat accumulation on regeneration
is undeﬁned.
Chronic steatosis has also been associated with adverse
outcomes after major hepatic resection in humans. A recent
meta-analysis showed that the risk of postoperative compli-
cations in patients with any degree of steatosis undergoing
hepatectomy (for neoplasm) was double that of their non-
steatotic counterparts, and that those with excessive (>30%)
steatosis had an almost 3-fold increased risk of death [92].
This analysis did not address whether impaired regeneration
was the culprit; however, a study of patients undergoing liver
resection (for living related liver donation) showed reduced
recovery of liver volume over the initial 3 months following
surgery in patients with mild steatosis (versus no steatosis,
[93]), and another study reported decreased recovery of liver
function 6–12 months after hepatectomy in such patients
[94]. These ﬁndings are consistent with the animal model
studies discussed above.
7. Summary andFutureInvestigations
As enumerated above, extensive older and more recent anal-
yses implicate alterations in adipose metabolism in re-
sponse to surgical- or toxin-induced hepatic insuﬃciencyInternational Journal of Hepatology 5
Partial hepatectomy- or toxin-induced hepatic insufﬁciency
Metabolic alterations (hypoglycemia and systemic catabolism)
Hepatic accumulation of adipose and lean mass-derived metabolites
Initiation of liver regeneration
Normalization of liver mass and function and hepatic and systemic metabolism
Termination of liver regeneration
Augmented: caloric restriction; supplementation with lipid 
Suppressed: ob/ob, db/db, KK-A(y) mice, Zucker rats, 
None or variable:orotic acid-, choline-, or  
Experimental manipulations employed to alter the 
metabolic response to PH:
Models of fatty liver disease (FLD) in which 
regeneration has been assessed:
None or variable: FASKOL, L-FABP KO, MTP-IKO, Caveolin1
KO, and PPARα KO mice.
Suppressed: supplementation with dextrose, leptin, 
propranolol, cloﬁbrate, Octanoylcarnitine;ﬂd, liver GRKO 
mice.
emulsion, palmitate/carnitine; streptozotocin-induced diabetes.
high-fructose diet-induced fatty liver disease.
methionine-choline-deﬁcient diet.
Figure 1: Am e t a b o l i cm o d e lo fl i v e rr e g e n e r a t i o n : the data reviewed here implicate the metabolic response to hepatic insuﬃciency as a source
of speciﬁc signals that initiate liver regeneration. Experimental manipulations employed to alter this metabolic response that are discussed
in the text are listed in the box to the left (along with their reported eﬀects on regeneration: suppressed, augmented, and none or variable
eﬀects). Models of fatty liver disease (FLD) in which regeneration has been assessed that are discussed in the text are listed in the box to the
right.(ﬂd:fattyliverdystrophymouse;GRKO:glucocorticoidreceptorknockout;FASKOL:liver-speciﬁcfattyacidsynthaseknockoutmouse;
L-Fabp KO: Liver fatty acid binding protein knockout; MTP-IKO: intestine-speciﬁc microsomal triglyceride transfer protein knockout;
PPAR: peroxisome proliferator-activated receptor).
as functionally important for initiation of normal liver
regeneration. However, the molecular basis for these eﬀects
has not yet been elucidated. Similarly, the mechanisms
responsible for the inhibitory eﬀect of chronic hepatic
steatosisonliverregenerationinexperimentalmodelsystems
and humans undergoing hepatic resection remain to be
established. It is tempting to speculate that the acute changes
in systemic lipid metabolism that occur in response to
hepatic insuﬃciency have speciﬁc, direct transcriptional,
and epigenetic proregenerative eﬀects, and that such events
are modiﬁed or reversed in chronic fatty liver disease.
Future studies should investigate the functional relationships
between these metabolic, genetic, and epigenetic alterations
during normal liver regeneration and examine the inﬂuence
of chronic hepatic steatosis on those relationships.
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